Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David D. Chang currently holds 4,810,106 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David D. Chang has been a net seller of ALLO stock. They have purchased $788.0K and sold $16.2M worth of shares.
David D. Chang's most recent insider trade was on May 16, 2024, when they sold 344,828 shares at $2.90 per share.
David D. Chang serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 89 insider transactions totaling $17.0M over their tenure at the company.
David D. Chang holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
David D. Chang has shown a selling trading pattern, with $788.0K in total purchases and $16.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David D. Chang was on Oct 3, 2017, when they sold $3.0M worth of KITE shares. This transaction involved 16,605 shares at $180.00 per share.
David D. Chang currently owns 4,810,106 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David D. Chang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David D. Chang has 89 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for David D. Chang and 40,000+ other insiders.